Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC and CRRT for Rhabdomyolysis
NCT00391911Phase 2Completed
- Sponsor
- Royal Alexandra Hospital
- Start
- Nov 2006
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of acetylcysteine in rhabdomyolysis (4 arms), sponsored by Royal Alexandra Hospital. Primary endpoints: Creatinine clearance, Myoglobin clearance and 1 more. Started Nov 2006; status: completed.
02
Drugs
acetylcysteine
03
Conditions
rhabdomyolysis
Beyond the preview
Go deeper on NCT00391911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00391911.